Atlas Trials

Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2D

Clinical trial NCT05856877 · UNKNOWN

Trial details

NCT number
NCT05856877
Sponsor
University Hospital Tuebingen
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Central Insulin ResistanceDiabetes Mellitus, Type 2PreDiabetes
Start date
2023-05-26
Primary completion
2025-05-31
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.